{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:42:44Z","timestamp":1792759364730,"version":"4.5.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T00:00:00Z","timestamp":1455580800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s10741-016-9536-9","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T06:33:11Z","timestamp":1455604391000},"page":"199-211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":269,"title":["The fibrosis-cell death axis in heart failure"],"prefix":"10.1007","volume":"21","author":[{"given":"A.","family":"Piek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. H. W.","family":"Sillj\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,16]]},"reference":[{"key":"9536_CR1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrm3902","volume":"12","author":"JK Mouw","year":"2014","unstructured":"Mouw JK, Ou G, Weaver VM (2014) Extracellular matrix assembly: a multiscale deconstruction. Nat Rev Mol Cell Biol 12:771\u2013785","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9536_CR2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","volume":"12","author":"C Bonnans","year":"2014","unstructured":"Bonnans C, Chou J, Werb Z (2014) Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 12:786\u2013801","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9536_CR3","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","volume":"12","author":"DC Rockey","year":"2015","unstructured":"Rockey DC, Bell PD, Hill JA (2015) Fibrosis: a common pathway to organ injury and failure. N Engl J Med 12:1138\u20131149","journal-title":"N Engl J Med"},{"key":"9536_CR4","first-page":"803","volume":"8","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 8:803\u2013869","journal-title":"Eur J Heart Fail"},{"key":"9536_CR5","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"16","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL et al (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 16:e147\u2013e239","journal-title":"J Am Coll Cardiol"},{"key":"9536_CR6","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","volume":"9","author":"A Mosterd","year":"2007","unstructured":"Mosterd A, Hoes AW (2007) Clinical epidemiology of heart failure. Heart 9:1137\u20131146","journal-title":"Heart"},{"key":"9536_CR7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/eurheartj\/14.suppl_C.24","volume":"14","author":"HN Sabbah","year":"1993","unstructured":"Sabbah HN, Goldstein S (1993) Ventricular remodelling: consequences and therapy. Eur Heart J 14:24\u201329","journal-title":"Eur Heart J"},{"key":"9536_CR8","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","volume":"19","author":"FP Brouwers","year":"2013","unstructured":"Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van Gilst WH (2013) Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 19:1424\u20131431","journal-title":"Eur Heart J"},{"key":"9536_CR9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"1","author":"BC Bernardo","year":"2010","unstructured":"Bernardo BC, Weeks KL, Pretorius L, McMullen JR (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 1:191\u2013227","journal-title":"Pharmacol Ther"},{"key":"9536_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1152\/physiol.00043.2010","volume":"2","author":"KL Weeks","year":"2011","unstructured":"Weeks KL, McMullen JR (2011) The athlete\u2019s heart vs. the failing heart: can signaling explain the two distinct outcomes? Physiology (Bethesda) 2:97\u2013105","journal-title":"Physiology (Bethesda)"},{"key":"9536_CR11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrm3495","volume":"1","author":"M Maillet","year":"2013","unstructured":"Maillet M, van Berlo JH, Molkentin JD (2013) Molecular basis of physiological heart growth: fundamental concepts and new players. Nat Rev Mol Cell Biol 1:38\u201348","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9536_CR12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1053-2498(03)00205-5","volume":"4","author":"H Milting","year":"2004","unstructured":"Milting H, Jacob M, Kassner A, Heimann P, Mannherz HG, Becker G, Meyer HE, Bothig D, Arusoglu L, Morshuis M et al (2004) The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling. J Heart Lung Transplant 4:396\u2013404","journal-title":"J Heart Lung Transplant"},{"key":"9536_CR13","doi-asserted-by":"crossref","first-page":"C216","DOI":"10.1152\/ajpcell.00328.2012","volume":"3","author":"M Zeisberg","year":"2013","unstructured":"Zeisberg M, Kalluri R (2013) Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am J Physiol Cell Physiol 3:C216\u2013C225","journal-title":"Am J Physiol Cell Physiol"},{"key":"9536_CR14","first-page":"158","volume":"2","author":"A n","year":"2011","unstructured":"n A, Frangogiannis NG (2011) Aging and cardiac fibrosis. Aging Dis 2:158\u2013173","journal-title":"Aging Dis"},{"key":"9536_CR15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/cvr\/cvq308","volume":"2","author":"EE Creemers","year":"2011","unstructured":"Creemers EE, Pinto YM (2011) Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 2:265\u2013272","journal-title":"Cardiovasc Res"},{"key":"9536_CR16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","volume":"2","author":"AM Segura","year":"2014","unstructured":"Segura AM, Frazier OH, Buja LM (2014) Fibrosis and heart failure. Heart Fail Rev 2:173\u2013185","journal-title":"Heart Fail Rev"},{"key":"9536_CR17","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","volume":"6","author":"KT Weber","year":"1991","unstructured":"Weber KT, Brilla CG (1991) Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 6:1849\u20131865","journal-title":"Circulation"},{"key":"9536_CR18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"4","author":"P Kong","year":"2014","unstructured":"Kong P, Christia P, Frangogiannis NG (2014) The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 4:549\u2013574","journal-title":"Cell Mol Life Sci"},{"key":"9536_CR19","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","volume":"7","author":"S Hein","year":"2003","unstructured":"Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, Bauer EP, Klovekorn WP, Schaper J (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 7:984\u2013991","journal-title":"Circulation"},{"key":"9536_CR20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCHEARTFAILURE.110.958223","volume":"2","author":"B Ky","year":"2011","unstructured":"Ky B, French B, McCloskey K, Rame JE, McIntosh E, Shahi P, Dries DL, Tang WH, Wu AH, Fang JC et al (2011) High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ Heart Fail 2:180\u2013187","journal-title":"Circ Heart Fail"},{"key":"9536_CR21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/07853890.2010.538080","volume":"1","author":"RA Boer de","year":"2011","unstructured":"de Boer RA, Lok DJ, Jaarsma T, van der Meer P, Voors AA, Hillege HL, van Veldhuisen DJ (2011) Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med 1:60\u201368","journal-title":"Ann Med"},{"key":"9536_CR22","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.bbadis.2012.12.014","volume":"12","author":"HK Gaggin","year":"2013","unstructured":"Gaggin HK, Januzzi JL Jr (2013) Biomarkers and diagnostics in heart failure. Biochim Biophys Acta 12:2442\u20132450","journal-title":"Biochim Biophys Acta"},{"key":"9536_CR23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/ejhf.203","volume":"2","author":"F Edelmann","year":"2015","unstructured":"Edelmann F, Holzendorf V, Wachter R, Nolte K, Schmidt AG, Kraigher-Krainer E, Duvinage A, Unkelbach I, Dungen HD, Tschope C et al (2015) Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial. Eur J Heart Fail 2:214\u2013223","journal-title":"Eur J Heart Fail"},{"key":"9536_CR24","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.jacc.2015.04.026","volume":"22","author":"B Lopez","year":"2015","unstructured":"Lopez B, Gonzalez A, Ravassa S, Beaumont J, Moreno MU, San Jose G, Querejeta R, Diez J (2015) Circulating biomarkers of myocardial fibrosis: the need for a reappraisal. J Am Coll Cardiol 22:2449\u20132456","journal-title":"J Am Coll Cardiol"},{"key":"9536_CR25","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1161\/CIRCULATIONAHA.110.942268","volume":"25","author":"I Kehat","year":"2010","unstructured":"Kehat I, Molkentin JD (2010) Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 25:2727\u20132735","journal-title":"Circulation"},{"key":"9536_CR26","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1038\/cddis.2011.130","volume":"2","author":"M Chiong","year":"2011","unstructured":"Chiong M, Wang ZV, Pedrozo Z, Cao DJ, Troncoso R, Ibacache M, Criollo A, Nemchenko A, Hill JA, Lavandero S (2011) Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis 2:e244","journal-title":"Cell Death Dis"},{"key":"9536_CR27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/CIRCRESAHA.109.207456","volume":"1","author":"R Kakkar","year":"2010","unstructured":"Kakkar R, Lee RT (2010) Intramyocardial fibroblast myocyte communication. Circ Res 1:47\u201357","journal-title":"Circ Res"},{"key":"9536_CR28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","volume":"1","author":"KT Weber","year":"2013","unstructured":"Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC (2013) Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 1:15\u201326","journal-title":"Nat Rev Cardiol"},{"key":"9536_CR29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"4","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 4:495\u2013516","journal-title":"Toxicol Pathol"},{"key":"9536_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cardiores.2005.04.012","volume":"1","author":"VP Empel van","year":"2005","unstructured":"van Empel VP, Bertrand AT, Hofstra L, Crijns HJ, Doevendans PA, De Windt LJ (2005) Myocyte apoptosis in heart failure. Cardiovasc Res 1:21\u201329","journal-title":"Cardiovasc Res"},{"key":"9536_CR31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1161\/CIRCRESAHA.110.225730","volume":"8","author":"G Kung","year":"2011","unstructured":"Kung G, Konstantinidis K, Kitsis RN (2011) Programmed necrosis, not apoptosis, in the heart. Circ Res 8:1017\u20131036","journal-title":"Circ Res"},{"key":"9536_CR32","first-page":"41","volume":"109","author":"AC Nag","year":"1980","unstructured":"Nag AC (1980) Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios 109:41\u201361","journal-title":"Cytobios"},{"key":"9536_CR33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cardiores.2004.08.020","volume":"1","author":"P Camelliti","year":"2005","unstructured":"Camelliti P, Borg TK, Kohl P (2005) Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res 1:40\u201351","journal-title":"Cardiovasc Res"},{"key":"9536_CR34","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.109.209809","volume":"12","author":"CA Souders","year":"2009","unstructured":"Souders CA, Bowers SL, Baudino TA (2009) Cardiac fibroblast: the renaissance cell. Circ Res 12:1164\u20131176","journal-title":"Circ Res"},{"key":"9536_CR35","first-page":"7430","volume":"11","author":"HL Fu","year":"2013","unstructured":"Fu HL, Valiathan RR, Arkwright R, Sohail A, Mihai C, Kumarasiri M, Mahasenan KV, Mobashery S, Huang P, Agarwal G et al (2013) Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling. J Biol Chem 11:7430\u20137437","journal-title":"J Biol Chem"},{"key":"9536_CR36","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/embo-reports\/kve094","volume":"5","author":"JP Labrador","year":"2001","unstructured":"Labrador JP, Azcoitia V, Tuckermann J, Lin C, Olaso E, Manes S, Bruckner K, Goergen JL, Lemke G, Yancopoulos G et al (2001) The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep 5:446\u2013452","journal-title":"EMBO Rep"},{"key":"9536_CR37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","volume":"5","author":"JJ Tomasek","year":"2002","unstructured":"Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 5:349\u2013363","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9536_CR38","doi-asserted-by":"crossref","first-page":"7409","DOI":"10.1074\/jbc.R400029200","volume":"9","author":"DB Rifkin","year":"2005","unstructured":"Rifkin DB (2005) Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J Biol Chem 9:7409\u20137412","journal-title":"J Biol Chem"},{"key":"9536_CR39","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrm2262","volume":"11","author":"P Dijke ten","year":"2007","unstructured":"ten Dijke P, Arthur HM (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 11:857\u2013869","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9536_CR40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1083\/jcb.122.1.103","volume":"1","author":"A Desmouliere","year":"1993","unstructured":"Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1:103\u2013111","journal-title":"J Cell Biol"},{"key":"9536_CR41","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.jid.5700613","volume":"3","author":"B Hinz","year":"2007","unstructured":"Hinz B (2007) Formation and function of the myofibroblast during tissue repair. J Investig Dermatol 3:526\u2013537","journal-title":"J Investig Dermatol"},{"key":"9536_CR42","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1091\/mbc.12.9.2730","volume":"9","author":"B Hinz","year":"2001","unstructured":"Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C (2001) Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 9:2730\u20132741","journal-title":"Mol Biol Cell"},{"key":"9536_CR43","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/CIRCRESAHA.111.244798","volume":"10","author":"C Rosker","year":"2011","unstructured":"Rosker C, Salvarani N, Schmutz S, Grand T, Rohr S (2011) Abolishing myofibroblast arrhythmogenicity by pharmacological ablation of alpha-smooth muscle actin containing stress fibers. Circ Res 10:1120\u20131131","journal-title":"Circ Res"},{"key":"9536_CR44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/CIRCHEARTFAILURE.110.960054","volume":"1","author":"NK Kapur","year":"2011","unstructured":"Kapur NK (2011) Transforming growth factor-beta: governing the transition from inflammation to fibrosis in heart failure with preserved left ventricular function. Circ Heart Fail 1:5\u20137","journal-title":"Circ Heart Fail"},{"key":"9536_CR45","doi-asserted-by":"crossref","first-page":"H512","DOI":"10.1152\/ajpheart.00137.2015","volume":"3","author":"K Yamagami","year":"2015","unstructured":"Yamagami K, Oka T, Wang Q, Ishizu T, Lee JK, Miwa K, Akazawa H, Naito AT, Sakata Y, Komuro I (2015) Pirfenidone exhibits cardioprotective effects by regulating myocardial fibrosis and vascular permeability in pressure-overloaded hearts. Am J Physiol Heart Circ Physiol 3:H512\u2013H522","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9536_CR46","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ajpath.2011.06.001","volume":"3","author":"S Piera-Velazquez","year":"2011","unstructured":"Piera-Velazquez S, Li Z, Jimenez SA (2011) Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 3:1074\u20131080","journal-title":"Am J Pathol"},{"key":"9536_CR47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00441-011-1222-6","volume":"1","author":"LA Meeteren van","year":"2012","unstructured":"van Meeteren LA, ten Dijke P (2012) Regulation of endothelial cell plasticity by TGF-beta. Cell Tissue Res 1:177\u2013186","journal-title":"Cell Tissue Res"},{"key":"9536_CR48","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","volume":"8","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB et al (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 8:952\u2013961","journal-title":"Nat Med"},{"key":"9536_CR49","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","volume":"7","author":"T Moore-Morris","year":"2014","unstructured":"Moore-Morris T, Guimaraes-Camboa N, Banerjee I, Zambon AC, Kisseleva T, Velayoudon A, Stallcup WB, Gu Y, Dalton ND, Cedenilla M et al (2014) Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J Clin Investig 7:2921\u20132934","journal-title":"J Clin Investig"},{"key":"9536_CR50","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCRESAHA.115.303794","volume":"7","author":"SR Ali","year":"2014","unstructured":"Ali SR, Ranjbarvaziri S, Talkhabi M, Zhao P, Subat A, Hojjat A, Kamran P, Muller AM, Volz KS, Tang Z et al (2014) Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation. Circ Res 7:625\u2013635","journal-title":"Circ Res"},{"key":"9536_CR51","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.RES.0000141429.13560.cb","volume":"6","author":"FJ Lange de","year":"2004","unstructured":"de Lange FJ, Moorman AF, Anderson RH, Manner J, Soufan AT, de Gier-de Vries C, Schneider MD, Webb S, van den Hoff MJ, Christoffels VM (2004) Lineage and morphogenetic analysis of the cardiac valves. Circ Res 6:645\u2013654","journal-title":"Circ Res"},{"key":"9536_CR52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/dvdy.20051","volume":"2","author":"J Lincoln","year":"2004","unstructured":"Lincoln J, Alfieri CM, Yutzey KE (2004) Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. Dev Dyn 2:239\u2013250","journal-title":"Dev Dyn"},{"key":"9536_CR53","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1182\/blood-2006-04-016600","volume":"9","author":"M Ogawa","year":"2006","unstructured":"Ogawa M, LaRue AC, Drake CJ (2006) Hematopoietic origin of fibroblasts\/myofibroblasts: its pathophysiologic implications. Blood 9:2893\u20132896","journal-title":"Blood"},{"key":"9536_CR54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/path.2281","volume":"3","author":"MJ Amerongen van","year":"2008","unstructured":"van Amerongen MJ, Bou-Gharios G, Popa E, van Ark J, Petersen AH, van Dam GM, van Luyn MJ, Harmsen MC (2008) Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J Pathol 3:377\u2013386","journal-title":"J Pathol"},{"key":"9536_CR55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.stem.2014.11.004","volume":"1","author":"R Kramann","year":"2015","unstructured":"Kramann R, Schneider RK, DiRocco DP, Machado F, Fleig S, Bondzie PA, Henderson JM, Ebert BL, Humphreys BD (2015) Perivascular Gli1\u00a0+\u00a0progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 1:51\u201366","journal-title":"Cell Stem Cell"},{"key":"9536_CR56","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","volume":"4","author":"FG Spinale","year":"2007","unstructured":"Spinale FG (2007) Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 4:1285\u20131342","journal-title":"Physiol Rev"},{"key":"9536_CR57","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S1053-2498(02)00557-0","volume":"7","author":"PJ Barton","year":"2003","unstructured":"Barton PJ, Birks EJ, Felkin LE, Cullen ME, Koban MU, Yacoub MH (2003) Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure. J Heart Lung Transplant 7:738\u2013744","journal-title":"J Heart Lung Transplant"},{"key":"9536_CR58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1152\/physiolgenomics.00148.2011","volume":"8","author":"B Lu","year":"2012","unstructured":"Lu B, Yu H, Zwartbol M, Ruifrok WP, van Gilst WH, de Boer RA, Sillje HH (2012) Identification of hypertrophy-and heart failure-associated genes by combining in vitro and in vivo models. Physiol Genom 8:443\u2013454","journal-title":"Physiol Genom"},{"key":"9536_CR59","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/cvr\/cvv002","volume":"2","author":"KM Herum","year":"2015","unstructured":"Herum KM, Lunde IG, Skrbic B, Louch WE, Hasic A, Boye S, Unger A, Brorson SH, Sjaastad I, Tonnessen T et al (2015) Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart. Cardiovasc Res 2:217\u2013226","journal-title":"Cardiovasc Res"},{"key":"9536_CR60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cvr\/cvt100","volume":"1","author":"B Lopez","year":"2013","unstructured":"Lopez B, Gonzalez A, Lindner D, Westermann D, Ravassa S, Beaumont J, Gallego I, Zudaire A, Brugnolaro C, Querejeta R et al (2013) Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase? Cardiovasc Res 1:111\u2013120","journal-title":"Cardiovasc Res"},{"key":"9536_CR61","author":"P Lu","year":"2011","unstructured":"Lu P, Takai K, Weaver VM, Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. doi: 10.1101\/cshperspect.a005058","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"9536_CR62","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.pharmtox.45.120403.095802","volume":"45","author":"RD Brown","year":"2005","unstructured":"Brown RD, Ambler SK, Mitchell MD, Long CS (2005) The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 45:657\u2013687","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9536_CR63","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/01.RES.0000129579.59664.9d","volume":"11","author":"S Verheule","year":"2004","unstructured":"Verheule S, Sato T, Everett T 4th, Engle SK, Otten D, Rubart-von der Lohe M, Nakajima HO, Nakajima H, Field LJ, Olgin JE (2004) Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res 11:1458\u20131465","journal-title":"Circ Res"},{"issue":"Suppl","key":"9536_CR64","first-page":"S24","volume":"3","author":"TH Everett 4th","year":"2007","unstructured":"Everett TH 4th, Olgin JE (2007) Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 3(Suppl):S24\u2013S27","journal-title":"Heart Rhythm"},{"key":"9536_CR65","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0008-6363(02)00273-0","volume":"2","author":"S Kostin","year":"2002","unstructured":"Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J (2002) Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2:361\u2013379","journal-title":"Cardiovasc Res"},{"key":"9536_CR66","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jacc.2007.09.064","volume":"8","author":"B Burstein","year":"2008","unstructured":"Burstein B, Nattel S (2008) Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 8:802\u2013809","journal-title":"J Am Coll Cardiol"},{"key":"9536_CR67","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/cvr\/cvq357","volume":"4","author":"AM Jong De","year":"2011","unstructured":"De Jong AM, Maass AH, Oberdorf-Maass SU, Van Veldhuisen DJ, Van Gilst WH, Van Gelder IC (2011) Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. Cardiovasc Res 4:754\u2013765","journal-title":"Cardiovasc Res"},{"key":"9536_CR68","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","volume":"4","author":"JS Burchfield","year":"2013","unstructured":"Burchfield JS, Xie M, Hill JA (2013) Pathological ventricular remodeling: mechanisms: part 1 of 2. Circulation 4:388\u2013400","journal-title":"Circulation"},{"key":"9536_CR69","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm.2124","volume":"4","author":"V Rudolph","year":"2010","unstructured":"Rudolph V, Andrie RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B, Schwoerer AP, Lau D, Fu X, Klingel K et al (2010) Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 4:470\u2013474","journal-title":"Nat Med"},{"key":"9536_CR70","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.114.302226","volume":"9","author":"J Heijman","year":"2014","unstructured":"Heijman J, Voigt N, Nattel S, Dobrev D (2014) Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ Res 9:1483\u20131499","journal-title":"Circ Res"},{"key":"9536_CR71","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jacc.2008.05.064","volume":"17","author":"EP Tsagalou","year":"2008","unstructured":"Tsagalou EP, Anastasiou-Nana M, Agapitos E, Gika A, Drakos SG, Terrovitis JV, Ntalianis A, Nanas JN (2008) Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol 17:1391\u20131398","journal-title":"J Am Coll Cardiol"},{"key":"9536_CR72","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1549-8719.2011.00130.x","volume":"1","author":"MP Boer De","year":"2012","unstructured":"De Boer MP, Meijer RI, Wijnstok NJ, Jonk AM, Houben AJ, Stehouwer CD, Smulders YM, Eringa EC, Serne EH (2012) Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Microcirculation 1:5\u201318","journal-title":"Microcirculation"},{"key":"9536_CR73","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0021-9258(17)42228-9","volume":"2","author":"MA Bogoyevitch","year":"1994","unstructured":"Bogoyevitch MA, Glennon PE, Andersson MB, Clerk A, Lazou A, Marshall CJ, Parker PJ, Sugden PH (1994) Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem 2:1110\u20131119","journal-title":"J Biol Chem"},{"key":"9536_CR74","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1172\/JCI118414","volume":"2","author":"D Kaye","year":"1996","unstructured":"Kaye D, Pimental D, Prasad S, Maki T, Berger HJ, McNeil PL, Smith TW, Kelly RA (1996) Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J Clin Investig 2:281\u2013291","journal-title":"J Clin Investig"},{"key":"9536_CR75","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1172\/JCI13627","volume":"12","author":"C Pellieux","year":"2001","unstructured":"Pellieux C, Foletti A, Peduto G, Aubert JF, Nussberger J, Beermann F, Brunner HR, Pedrazzini T (2001) Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2. J Clin Investig 12:1843\u20131851","journal-title":"J Clin Investig"},{"key":"9536_CR76","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2353\/ajpath.2007.070003","volume":"5","author":"JA Virag","year":"2007","unstructured":"Virag JA, Rolle ML, Reece J, Hardouin S, Feigl EO, Murry CE (2007) Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function. Am J Pathol 5:1431\u20131440","journal-title":"Am J Pathol"},{"key":"9536_CR77","first-page":"143","volume":"4","author":"SL House","year":"2010","unstructured":"House SL, House BE, Glascock B, Kimball T, Nusayr E, Schultz JE, Doetschman T (2010) Fibroblast growth factor 2 mediates isoproterenol-induced cardiac hypertrophy through activation of the extracellular regulated kinase. Mol Cell Pharmacol 4:143\u2013154","journal-title":"Mol Cell Pharmacol"},{"key":"9536_CR78","doi-asserted-by":"crossref","first-page":"e35144","DOI":"10.1371\/journal.pone.0035144","volume":"5","author":"F Ma","year":"2012","unstructured":"Ma F, Li Y, Jia L, Han Y, Cheng J, Li H, Qi Y, Du J (2012) Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF beta\/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS ONE 5:e35144","journal-title":"PLoS ONE"},{"key":"9536_CR79","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.109.148635","volume":"2","author":"GC Melendez","year":"2010","unstructured":"Melendez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL (2010) Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 2:225\u2013231","journal-title":"Hypertension"},{"key":"9536_CR80","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1172\/JCI40295","volume":"1","author":"N Takeda","year":"2010","unstructured":"Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, Shindo T, Sano M, Otsu K, Snider P et al (2010) Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Investig 1:254\u2013265","journal-title":"J Clin Investig"},{"key":"9536_CR81","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrcardio.2014.125","volume":"11","author":"T Thum","year":"2014","unstructured":"Thum T (2014) Noncoding RNAs and myocardial fibrosis. Nat Rev Cardiol 11:655\u2013663","journal-title":"Nat Rev Cardiol"},{"key":"9536_CR82","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","volume":"7224","author":"T Thum","year":"2008","unstructured":"Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S et al (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 7224:980\u2013984","journal-title":"Nature"},{"key":"9536_CR83","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1172\/JCI43604","volume":"11","author":"DM Patrick","year":"2010","unstructured":"Patrick DM, Montgomery RL, Qi X, Obad S, Kauppinen S, Hill JA, van Rooij E, Olson EN (2010) Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Investig 11:3912\u20133916","journal-title":"J Clin Investig"},{"key":"9536_CR84","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","volume":"35","author":"E Rooij van","year":"2008","unstructured":"van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 35:13027\u201313032","journal-title":"Proc Natl Acad Sci USA"},{"key":"9536_CR85","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/mt.2014.25","volume":"5","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Huang XR, Wei LH, Chung AC, Yu CM, Lan HY (2014) miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-beta\/Smad3 signaling. Mol Ther 5:974\u2013985","journal-title":"Mol Ther"},{"key":"9536_CR86","doi-asserted-by":"crossref","first-page":"15883","DOI":"10.1073\/pnas.2136717100","volume":"26","author":"O Yamaguchi","year":"2003","unstructured":"Yamaguchi O, Higuchi Y, Hirotani S, Kashiwase K, Nakayama H, Hikoso S, Takeda T, Watanabe T, Asahi M, Taniike M et al (2003) Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proc Natl Acad Sci USA 26:15883\u201315888","journal-title":"Proc Natl Acad Sci USA"},{"key":"9536_CR87","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbrc.2005.05.151","volume":"2","author":"T Watanabe","year":"2005","unstructured":"Watanabe T, Otsu K, Takeda T, Yamaguchi O, Hikoso S, Kashiwase K, Higuchi Y, Taniike M, Nakai A, Matsumura Y et al (2005) Apoptosis signal-regulating kinase 1 is involved not only in apoptosis but also in non-apoptotic cardiomyocyte death. Biochem Biophys Res Commun 2:562\u2013567","journal-title":"Biochem Biophys Res Commun"},{"key":"9536_CR88","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCRESAHA.109.200741","volume":"11","author":"Q Liu","year":"2009","unstructured":"Liu Q, Sargent MA, York AJ, Molkentin JD (2009) ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice. Circ Res 11:1110\u20131117","journal-title":"Circ Res"},{"key":"9536_CR89","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jacc.2007.03.053","volume":"5","author":"S Hikoso","year":"2007","unstructured":"Hikoso S, Ikeda Y, Yamaguchi O, Takeda T, Higuchi Y, Hirotani S, Kashiwase K, Yamada M, Asahi M, Matsumura Y et al (2007) Progression of heart failure was suppressed by inhibition of apoptosis signal-regulating kinase 1 via transcoronary gene transfer. J Am Coll Cardiol 5:453\u2013462","journal-title":"J Am Coll Cardiol"},{"key":"9536_CR90","first-page":"H1143","volume":"9","author":"QQ Wu","year":"2015","unstructured":"Wu QQ, Xu M, Yuan Y, Li FF, Yang Z, Liu Y, Zhou MQ, Bian ZY, Deng W, Gao L et al (2015) Cathepsin B deficiency attenuates cardiac remodeling in response to pressure overload via TNF-alpha\/ASK1\/JNK pathway. Am J Physiol Heart Circ Physiol 9:H1143\u2013H1154","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9536_CR91","doi-asserted-by":"crossref","first-page":"e68668","DOI":"10.1371\/journal.pone.0068668","volume":"7","author":"K Porter","year":"2013","unstructured":"Porter K, Lin Y, Liton PB (2013) Cathepsin B is up-regulated and mediates extracellular matrix degradation in trabecular meshwork cells following phagocytic challenge. PLoS ONE 7:e68668","journal-title":"PLoS ONE"},{"key":"9536_CR92","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1074\/jbc.M509056200","volume":"3","author":"AS Galvez","year":"2006","unstructured":"Galvez AS, Brunskill EW, Marreez Y, Benner BJ, Regula KM, Kirschenbaum LA, Dorn GW 2nd (2006) Distinct pathways regulate proapoptotic Nix and BNip3 in cardiac stress. J Biol Chem 3:1442\u20131448","journal-title":"J Biol Chem"},{"key":"9536_CR93","first-page":"497","volume":"4","author":"GW Dorn 2nd","year":"2011","unstructured":"Dorn GW 2nd (2011) Nix Nought Nothing: fairy tale or real deal. J Mol Cell Cardiol 4:497\u2013500","journal-title":"J Mol Cell Cardiol"},{"key":"9536_CR94","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/CIRCULATIONAHA.107.727073","volume":"3","author":"A Diwan","year":"2008","unstructured":"Diwan A, Wansapura J, Syed FM, Matkovich SJ, Lorenz JN, Dorn GW 2nd (2008) Nix-mediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation. Circulation 3:396\u2013404","journal-title":"Circulation"},{"key":"9536_CR95","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cvr\/cvu264","volume":"3","author":"JE Cartledge","year":"2015","unstructured":"Cartledge JE, Kane C, Dias P, Tesfom M, Clarke L, Mckee B, Al Ayoubi S, Chester A, Yacoub MH, Camelliti P et al (2015) Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators. Cardiovasc Res 3:260\u2013270","journal-title":"Cardiovasc Res"},{"key":"9536_CR96","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1139\/Y08-051","volume":"8","author":"A Ren","year":"2008","unstructured":"Ren A, Yan X, Lu H, Shi J, Yin Y, Bai J, Yuan W, Lin L (2008) Antagonism of endothelin-1 inhibits hypoxia-induced apoptosis in cardiomyocytes. Can J Physiol Pharmacol 8:536\u2013540","journal-title":"Can J Physiol Pharmacol"},{"key":"9536_CR97","first-page":"56","volume":"1","author":"A Desmouliere","year":"1995","unstructured":"Desmouliere A, Redard M, Darby I, Gabbiani G (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1:56\u201366","journal-title":"Am J Pathol"},{"key":"9536_CR98","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","volume":"4","author":"B Hinz","year":"2012","unstructured":"Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmouliere A, Varga J, De Wever O, Mareel M, Gabbiani G (2012) Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 4:1340\u20131355","journal-title":"Am J Pathol"},{"key":"9536_CR99","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/path.1427","volume":"4","author":"G Gabbiani","year":"2003","unstructured":"Gabbiani G (2003) The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 4:500\u2013503","journal-title":"J Pathol"},{"key":"9536_CR100","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","volume":"3","author":"JP Iredale","year":"1998","unstructured":"Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ (1998) Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Investig 3:538\u2013549","journal-title":"J Clin Investig"},{"key":"9536_CR101","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1523-1755.2001.059002579.x","volume":"2","author":"F Strutz","year":"2001","unstructured":"Strutz F, Zeisberg M, Renziehausen A, Raschke B, Becker V, van Kooten C, Muller G (2001) TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int 2:579\u2013592","journal-title":"Kidney Int"},{"key":"9536_CR102","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1096\/fj.03-0699com","volume":"3","author":"GR Grotendorst","year":"2004","unstructured":"Grotendorst GR, Rahmanie H, Duncan MR (2004) Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J 3:469\u2013479","journal-title":"FASEB J"},{"key":"9536_CR103","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1006\/jmcc.1996.0185","volume":"9","author":"AV Sigel","year":"1996","unstructured":"Sigel AV, Centrella M, Eghbali-Webb M (1996) Regulation of proliferative response of cardiac fibroblasts by transforming growth factor-beta 1. J Mol Cell Cardiol 9:1921\u20131929","journal-title":"J Mol Cell Cardiol"},{"key":"9536_CR104","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1165\/rcmb.2008-0447OC","volume":"4","author":"P Kulasekaran","year":"2009","unstructured":"Kulasekaran P, Scavone CA, Rogers DS, Arenberg DA, Thannickal VJ, Horowitz JC (2009) Endothelin-1 and transforming growth factor-beta1 independently induce fibroblast resistance to apoptosis via AKT activation. Am J Respir Cell Mol Biol 4:484\u2013493","journal-title":"Am J Respir Cell Mol Biol"},{"key":"9536_CR105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1513\/pats.200601-001TK","volume":"4","author":"VJ Thannickal","year":"2006","unstructured":"Thannickal VJ, Horowitz JC (2006) Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 4:350\u2013356","journal-title":"Proc Am Thorac Soc"},{"key":"9536_CR106","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2165\/11591490-000000000-00000","volume":"8","author":"Q Ding","year":"2011","unstructured":"Ding Q, Luckhardt T, Hecker L, Zhou Y, Liu G, Antony VB, deAndrade J, Thannickal VJ (2011) New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis. Drugs 8:981\u20131001","journal-title":"Drugs"},{"key":"9536_CR107","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0344-0338(96)80092-6","volume":"7","author":"G Gabbiani","year":"1996","unstructured":"Gabbiani G (1996) The cellular derivation and the life span of the myofibroblast. Pathol Res Pract 7:708\u2013711","journal-title":"Pathol Res Pract"},{"key":"9536_CR108","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/cvr\/cvt338","volume":"3","author":"RB Driesen","year":"2014","unstructured":"Driesen RB, Nagaraju CK, Abi-Char J, Coenen T, Lijnen PJ, Fagard RH, Sipido KR, Petrov VV (2014) Reversible and irreversible differentiation of cardiac fibroblasts. Cardiovasc Res 3:411\u2013422","journal-title":"Cardiovasc Res"},{"key":"9536_CR109","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejcb.2013.10.013","volume":"12","author":"J Kosla","year":"2013","unstructured":"Kosla J, Dvorakova M, Dvorak M, Cermak V (2013) Effective myofibroblast dedifferentiation by concomitant inhibition of TGF-beta signaling and perturbation of MAPK signaling. Eur J Cell Biol 12:363\u2013373","journal-title":"Eur J Cell Biol"},{"key":"9536_CR110","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/cvr\/cvv155","volume":"4","author":"D Sawaki","year":"2015","unstructured":"Sawaki D, Hou L, Tomida S, Sun J, Zhan H, Aizawa K, Son BK, Kariya T, Takimoto E, Otsu K et al (2015) Modulation of cardiac fibrosis by Kruppel-like factor 6 through transcriptional control of thrombospondin 4 in cardiomyocytes. Cardiovasc Res 4:420\u2013430","journal-title":"Cardiovasc Res"},{"key":"9536_CR111","first-page":"30","volume":"1","author":"E Oikonomou","year":"2011","unstructured":"Oikonomou E, Tousoulis D, Siasos G, Zaromitidou M, Papavassiliou AG, Stefanadis C (2011) The role of inflammation in heart failure: new therapeutic approaches. Hell J Cardiol 1:30\u201340","journal-title":"Hell J Cardiol"},{"key":"9536_CR112","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/hrt.2002.007005","volume":"4","author":"SD Anker","year":"2004","unstructured":"Anker SD, von Haehling S (2004) Inflammatory mediators in chronic heart failure: an overview. Heart 4:464\u2013470","journal-title":"Heart"},{"key":"9536_CR113","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1071-9164(96)80047-9","volume":"3","author":"Y Seta","year":"1996","unstructured":"Seta Y, Shan K, Bozkurt B, Oral H, Mann DL (1996) Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 3:243\u2013249","journal-title":"J Card Fail"},{"key":"9536_CR114","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/CIRCULATIONAHA.104.508465","volume":"10","author":"IS Anand","year":"2005","unstructured":"Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, Signorini S, Mocarelli P, Hester A, Glazer R et al (2005) C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 10:1428\u20131434","journal-title":"Circulation"},{"key":"9536_CR115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0735-1097(97)00494-4","volume":"2","author":"T Tsutamoto","year":"1998","unstructured":"Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M, Kinoshita M (1998) Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 2:391\u2013398","journal-title":"J Am Coll Cardiol"},{"key":"9536_CR116","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","volume":"4","author":"B Levine","year":"1990","unstructured":"Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 4:236\u2013241","journal-title":"N Engl J Med"},{"key":"9536_CR117","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.amjcard.2006.04.018","volume":"6","author":"WH Tang","year":"2006","unstructured":"Tang WH, Brennan ML, Philip K, Tong W, Mann S, Van Lente F, Hazen SL (2006) Plasma myeloperoxidase levels in patients with chronic heart failure. Am J Cardiol 6:796\u2013799","journal-title":"Am J Cardiol"},{"key":"9536_CR118","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/phrs.1998.0463","volume":"2","author":"R Ferrari","year":"1999","unstructured":"Ferrari R (1999) The role of TNF in cardiovascular disease. Pharmacol Res 2:97\u2013105","journal-title":"Pharmacol Res"},{"key":"9536_CR119","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00005-009-0024-y","volume":"3","author":"M Bujak","year":"2009","unstructured":"Bujak M, Frangogiannis NG (2009) The role of IL-1 in the pathogenesis of heart disease. Arch Immunol Ther Exp (Warsz) 3:165\u2013176","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"9536_CR120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032713-120257","volume":"32","author":"MA Travis","year":"2014","unstructured":"Travis MA, Sheppard D (2014) TGF-beta activation and function in immunity. Annu Rev Immunol 32:51\u201382","journal-title":"Annu Rev Immunol"},{"issue":"11 Suppl 1","key":"9536_CR121","first-page":"II-180","volume":"110","author":"V Jayasankar","year":"2004","unstructured":"Jayasankar V, Woo YJ, Bish LT, Pirolli TJ, Berry MF, Burdick J, Bhalla RC, Sharma RV, Gardner TJ, Sweeney HL (2004) Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy. Circulation 110(11 Suppl 1):II-180","journal-title":"Circulation"},{"issue":"1","key":"9536_CR122","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/cvr\/cvv214","volume":"109","author":"J Gonz\u00e1lez-Santamar\u00eda","year":"2016","unstructured":"Gonz\u00e1lez-Santamar\u00eda J, Villalba M, Busnadiego O, L\u00f3pez-Ola\u00f1eta MM, Sandoval P, Snabel J, L\u00f3pez-Cabrera M, Erler JT, Hanemaaijer R, Lara-Pezzi E, Rodr\u00edguez-Pascual F (2016) Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction. Cardiovasc Res 109(1):67\u201378","journal-title":"Cardiovasc Res"},{"key":"9536_CR123","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","volume":"1","author":"L Yu","year":"2013","unstructured":"Yu L, Ruifrok WP, Meissner M, Bos EM, van Goor H, Sanjabi B, van der Harst P, Pitt B, Goldstein IJ, Koerts JA et al (2013) Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis. Circ Heart Fail 1:107\u2013117","journal-title":"Circ Heart Fail"},{"key":"9536_CR124","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1177\/0192623311416259","volume":"6","author":"MJ Anderton","year":"2011","unstructured":"Anderton MJ, Mellor HR, Bell A, Sadler C, Pass M, Powell S, Steele SJ, Roberts RR, Heier A (2011) Induction of heart valve lesions by small-molecule ALK5 inhibitors. Toxicol Pathol 6:916\u2013924","journal-title":"Toxicol Pathol"},{"key":"9536_CR125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.yjmcc.2014.08.008","volume":"76","author":"KV Engebretsen","year":"2014","unstructured":"Engebretsen KV, Skardal K, Bjornstad S, Marstein HS, Skrbic B, Sjaastad I, Christensen G, Bjornstad JL, Tonnessen T (2014) Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5. J Mol Cell Cardiol 76:148\u2013157","journal-title":"J Mol Cell Cardiol"},{"key":"9536_CR126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2013.06.002","volume":"1","author":"NA Turner","year":"2014","unstructured":"Turner NA (2014) Effects of interleukin-1 on cardiac fibroblast function: relevance to post-myocardial infarction remodelling. Vasc Pharmacol 1:1\u20137","journal-title":"Vasc Pharmacol"},{"issue":"3","key":"9536_CR127","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/CIRCULATIONAHA.115.018174","volume":"133","author":"V Nagpal","year":"2015","unstructured":"Nagpal V, Rai R, Place AT, Murphy SB, Verma SK, Ghosh AK, Vaughan DE (2015) MiR-125b is critical for fibroblast-to-myofibroblast transition and cardiac fibrosis. Circulation 133(3):291\u2013301","journal-title":"Circulation"},{"key":"9536_CR128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature11139","volume":"7400","author":"K Song","year":"2012","unstructured":"Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG et al (2012) Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 7400:599\u2013604","journal-title":"Nature"},{"key":"9536_CR129","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.1301019110","volume":"14","author":"YJ Nam","year":"2013","unstructured":"Nam YJ, Song K, Luo X, Daniel E, Lambeth K, West K, Hill JA, DiMaio JM, Baker LA, Bassel-Duby R et al (2013) Reprogramming of human fibroblasts toward a cardiac fate. Proc Natl Acad Sci USA 14:5588\u20135593","journal-title":"Proc Natl Acad Sci USA"},{"key":"9536_CR130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.3147","volume":"4","author":"YJ Nam","year":"2013","unstructured":"Nam YJ, Song K, Olson EN (2013) Heart repair by cardiac reprogramming. Nat Med 4:413\u2013415","journal-title":"Nat Med"},{"key":"9536_CR131","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"6","author":"VL Roger","year":"2013","unstructured":"Roger VL (2013) Epidemiology of heart failure. Circ Res 6:646\u2013659","journal-title":"Circ Res"},{"key":"9536_CR132","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1089\/hum.2013.2512","volume":"11","author":"JK Gwathmey","year":"2013","unstructured":"Gwathmey JK, Yerevanian A, Hajjar RJ (2013) Targeting sarcoplasmic reticulum calcium ATPase by gene therapy. Hum Gene Ther 11:937\u2013947","journal-title":"Hum Gene Ther"},{"key":"9536_CR133","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1073\/pnas.97.2.793","volume":"2","author":"MI Miyamoto","year":"2000","unstructured":"Miyamoto MI, del Monte F, Schmidt U, DiSalvo TS, Kang ZB, Matsui T, Guerrero JL, Gwathmey JK, Rosenzweig A, Hajjar RJ (2000) Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA 2:793\u2013798","journal-title":"Proc Natl Acad Sci USA"},{"key":"9536_CR134","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","volume":"3","author":"M Jessup","year":"2011","unstructured":"Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky A, Zsebo KM, Dittrich H, Hajjar RJ et al (2011) Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 3:304\u2013313","journal-title":"Circulation"},{"key":"9536_CR135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10741-009-9135-0","volume":"4","author":"JR Teerlink","year":"2009","unstructured":"Teerlink JR (2009) A novel approach to improve cardiac performance: cardiac myosin activators. Heart Fail Rev 4:289\u2013298","journal-title":"Heart Fail Rev"},{"key":"9536_CR136","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.yjmcc.2011.05.006","volume":"4","author":"FI Malik","year":"2011","unstructured":"Malik FI, Morgan BP (2011) Cardiac myosin activation part 1: from concept to clinic. J Mol Cell Cardiol 4:454\u2013461","journal-title":"J Mol Cell Cardiol"},{"key":"9536_CR137","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1517\/13543784.2016.1123248","volume":"25","author":"LC Liu","year":"2016","unstructured":"Liu LC, Dorhout B, van der Meer P, Teerlink JR, Voors AA (2016) Omecamtiv mecarbil: a novel cardiac myosin activator for the treatment of heart failure. Expert Opin Investig Drugs 25:117\u2013127","journal-title":"Expert Opin Investig Drugs"},{"key":"9536_CR138","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00395-012-0324-y","volume":"108","author":"M Park","year":"2013","unstructured":"Park M, Vatner SF, Yan L, Gao S, Yoon S, Lee GJ, Xie LH, Kitsis RN, Vatner DE (2013) Novel mechanisms for caspase inhibition protecting cardiac function with chronic pressure overload. Basic Res Cardiol 108:324","journal-title":"Basic Res Cardiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-016-9536-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-016-9536-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-016-9536-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T07:32:00Z","timestamp":1654327920000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-016-9536-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,16]]},"references-count":138,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["9536"],"URL":"https:\/\/doi.org\/10.1007\/s10741-016-9536-9","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,16]]}}}